Product Information
DEXMETHYLPHENIDATE ER 35 MG CP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $2.0715 per EA under NDC 00115171001. Its NADAC has been published 407 times since Dec 19, 2018.
FDA first approved this application on Jul 5, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
35 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115171001
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203614FDA Approved
7/5/2017
TE Code
AB
On Market Since
7/5/2017
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 35 MG CP has been published 407 times since Dec 19, 2018, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0715 per EA |
|---|---|
| All-time high | $3.7935 (Jul 10, 2019) |
| All-time low | $1.1390 (Dec 21, 2022) |
| 52-week high | $2.5971 |
| 52-week low | $1.9329 |
| Median price | $2.4436 |
| Average price | $2.3975 |
| Largest weekly change | +55.4% (Apr 26, 2023) |
| Weeks tracked | 407 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexmethylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 35 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 35 MG CP, manufactured by Amneal Pharmaceuticals of New York LLC, is $2.0715 per EA (NDC 00115171001), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE ER 35 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 35 MG CP has declined 2.3%. It has been tracked across 407 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 35 MG CP?
Since Dec 19, 2018, the NADAC for DEXMETHYLPHENIDATE ER 35 MG CP has ranged from a low of $1.1390 (Dec 21, 2022) to a high of $3.7935 (Jul 10, 2019), with a median of $2.4436 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 35 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of DEXMETHYLPHENIDATE ER 35 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXMETHYLPHENIDATE ER 35 MG CP?
DEXMETHYLPHENIDATE ER 35 MG CP (NDC 00115171001) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.